MedTrace Logo

Prebiotics in Patients With Non-alcoholic Liver Disease

NCT02642172 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-11-29

No results posted yet for this study

Summary

The purpose of this present study is to evaluating whether prebiotics - ITF (Inulin/OFS 75/25) is effective in treating patients with non-alcoholic liver disease.

Conditions

  • Non-alcoholic Fatty Liver Disease
  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

ITF (Inulin/OFS 75/25)

Participants will consume 16 g/day ITF

DIETARY_SUPPLEMENT

Placebo

Participants will consume 16 g/day maltodextrin

Sponsors & Collaborators

  • Kaplan Medical Center

    lead OTHER

Principal Investigators

  • Yaakov Maor, Dr · Kaplan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2023-03-20
Completion
2023-03-20

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02642172 on ClinicalTrials.gov